If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFinseta Regulatory News (FIN)

Share Price Information for Finseta (FIN)

Share Price is delayed by 15 minutes
Get Live Data
13.25    0.00 (0.00%)
Bid:
13.00
Ask:
13.50
Spread: 0.50 (3.846%)
Market Cap: £9.33m
FIN Live PriceLast checked at - London Stock Exchange

Intraday Finseta Share Chart

Statement from Co-Chairman Dr B.R. Shetty

29 Apr 2020 10:50

RNS Number : 3154L
Finablr PLC
29 April 2020
 

29 April 2020

 

Finablr PLC ("Finablr" or the "Company")

 

Statement from Co-Chairman Dr B.R. Shetty

 

 

The Company notes the Statement made Co-Chairman Dr B.R. Shetty as set out below in full. The Company takes all allegations of fraud and wrongdoing with the utmost seriousness and will continue actively to pursue all available lines of enquiry.

 

 

 Statement from Dr B.R. Shetty

Out of respect for due process and to allow the various UK and UAE authorities and investigations, including my own, to quickly expedite their mandates, I have refrained, to date, from making any extensive public statements. This restraint in speaking out has come at great personal cost to me both reputationally and materially. However, given my own legal and forensic investigations are now starting to produce some initial findings, and in consideration of some misleading and inaccurate allegations and claims made against me, now is the right time to do so.

For the sake of clarity, I ceased having a day-to-day executive role in NMC Health PLC ('NMC') in 2017 and since then I have been a joint non-executive chairman and shareholder of NMC. I stepped down from the board of NMC on February 16th, 2020. The series of events since December 2019 have shocked me as much as anyone else, including the alleged fraud and misconduct at NMC, as well as the existence and extent of undisclosed company debts.

The preliminary findings provided by my advisors from my own investigations indicate that serious fraud and wrongdoing appears to have taken place at NMC, Finablr PLC ('Finablr'), as well as within some of my private companies, and against me personally. This fraud also appears to have been undertaken by a small group of current and former executives at these companies.

Some of these preliminary findings include, but are not limited to;

• The fraudulent creation and operating of bank accounts in my name including many fraudulent transfers that I neither authorised, consented to, or had any knowledge of.

• The fraudulent creation of loans, personal guarantees, cheques and bank transfers in my name, and using my forged signature, that I neither authorised, consented to, or had any knowledge of.

• The creation and set-up of companies in my name that I neither authorised, consented to, or had any knowledge of, and that were seemingly created with the express intention to commit or conceal fraud.

• The fraudulent creation of powers of attorney, and the misuse of existing powers of attorney, again in my name, that I that I neither authorised, consented to, or had any knowledge of.

• The creation and provision to me of false and misleading financial statements and information regarding the performance of some of my private companies and investments by members of my own management team.

• The payments of expenses using my private companies and personal bank accounts, I believe to hide the true financials of the public companies.

My advisors and I have therefore shared information and evidence from our findings with all relevant boards, as well as with relevant law enforcement and regulatory authorities. We will continue to proactively share this information as this work continues and in order to assist these parties with their own investigations and inquiries.

 

I remain fully committed to working with both companies and all relevant authorities in the UAE and UK to ensure that all stakeholders are provided with as full and comprehensive an understanding of the entire situation as I can, as well as all the facts as I know them, as quickly as possible.

I am vigorously pursuing, all legal actions and remedies available to me against those who have committed fraud against my businesses and myself.

The businesses my family and I have started in the UAE, and elsewhere, over the last 45 years were established on the fundamental principles of hard work, determination, decency, integrity and trust. This great country has provided a hugely supportive environment in which to establish and grow our businesses and it has bestowed countless blessings on my family and I. In return, we had hoped to provide some benefit and service to its citizens and residents.

To see everything that my family and I have strived to build over the past 45 years eroded over the course of a few short months, and mainly due to the misconduct and wrongdoing of people I put so much trust in, saddens me beyond words. It has also left my entire family in a perilous financial position.

My greatest regret is for the thousands of hardworking employees in the companies we established who are now enduring extreme uncertainty and hardship, especially during the current public health crisis. It also pains me to see the damage caused to my business partners, shareholders and other stakeholders who we have worked with for so long.

I intend to work tirelessly to clear my name and assist any authorities in getting to the truth and help them ensure that misappropriated or missing funds are returned by the perpetrators to their rightful owners.

 

 

Dr B.R. Shetty

 

 

 

 

END

 

 

Enquiries

 

The Company

Finablr PLC 

Robert Moorhouse, Group Company Secretary +44 7825 213767

Ryan Ayache, Head of Investor Relations +971 2 3073 176

 

For more information, visit the Finablr website: www.finablr.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRKKCBQCBKKOQB
Date   Source Headline
8th Jan 20207:00 amRNSStatement re Travelex update on cyber incident
7th Jan 20205:36 pmRNSShare sale in NMC Health PLC and Finablr PLC
2nd Jan 20206:14 pmRNSStatement regarding Travelex IT issues
19th Dec 20193:59 pmRNSDirector/PDMR Shareholding
19th Dec 20193:59 pmRNSDirector/PDMR Shareholding
19th Dec 20193:59 pmRNSDirector/PDMR Shareholding
18th Dec 20197:24 amRNSStatement re recent share price volatility
25th Nov 20191:51 pmRNSDirector/PDMR Shareholding
15th Nov 20197:00 amRNSAppointment of Corporate Brokers
11th Nov 20197:00 amRNSTrading Update
6th Nov 20197:00 amRNSCompletion of Capital Reduction
5th Nov 201912:02 pmRNSPrice Monitoring Extension
4th Nov 20194:41 pmRNSSecond Price Monitoring Extn
4th Nov 20194:35 pmRNSPrice Monitoring Extension
30th Oct 201912:07 pmRNSSecond Price Monitoring Extn
30th Oct 201912:02 pmRNSPrice Monitoring Extension
22nd Oct 20194:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20194:35 pmRNSPrice Monitoring Extension
3rd Oct 20197:00 amRNSFinablr and Samsung announce partnership
27th Sep 20194:40 pmRNSSecond Price Monitoring Extn
27th Sep 20194:35 pmRNSPrice Monitoring Extension
21st Aug 20192:19 pmRNSHolding(s) in Company
21st Aug 20192:19 pmRNSHolding(s) in Company
20th Aug 20197:00 amRNSHalf-year Report
16th Aug 201912:47 pmRNSAppointment of Non-Executive Director
31st Jul 20197:00 amRNSLondon Heathrow Concession Agreement Renewed
8th Jul 20197:25 amRNSDirector/PDMR Shareholding
2nd Jul 201910:18 amRNSFinablr to Report Interim 2019 Results in August
14th Jun 20197:00 amRNSStabilisation Notice
12th Jun 20199:30 amRNSStabilisation Notice
5th Jun 20198:54 amRNSStabilisation Notice
5th Jun 20197:00 amRNSDirector/PDMR Shareholding
31st May 20197:00 amRNSNOTIFICATION OF VOTING RIGHTS AND CAPITAL
30th May 20197:31 amRNSTravelex Q1 results
29th May 20199:54 amRNSStabilisation Notice
22nd May 201910:44 amRNSStabilisation Notice
20th May 20197:00 amRNSAdmission to Trading on the London Stock Exchange
15th May 20192:26 pmRNSApproval and Publication of Prospectus
15th May 20197:00 amRNSStabilisation Notice
15th May 20197:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.